LACI-3 trial – LACunar Intervention trial 3

Trial documents

Emergency numbers	This page does not provide the emergency mobile numbers. Please log in to view them, or bookmark the main documents page instead of this one.

Approved protocol	Protocol 20250130 V3.0.pdf

Trial documents	Dose Escalation and Symptom Management Guide v 2.0 02.10.2025 Final.pdf (updated 19 days ago) Eligibility Assessment Guide v 3.0 25.09.25.pdf Eligibility Checklist v.3.0 21.07.2025.pdf Eligibility Recording v 1.0 12.06.2025.pdf Recruitment Checklist v.4.0 21.09.2025.pdf Recruitment Script v 1.0 13.06.2025.pdf Study PACK Cilostazol v 2.0 4 August 2025.docx Study PACK ISMN XL Cilostazol v 2.0 4 August 2025.docx Study PACK ISMN XL v 2.0 4 August 2025.docx Study PACK ISMN non-XL 20mg Cilostazol v 3.0 4 August 2025.docx Study PACK ISMN non XL 20 mg v 2.0 4 August 2025.docx

Information sheets and consent forms	Facts Sheet 20241021 V1.0.pdf Participant Consent Form 20241021 V1.0.pdf Participant Information Sheet 20250516 V 3.0.pdf

Printable CRFs	(updated 36 days ago) Randomisation v1.1 Baseline v1.0 Week 1-2 follow-up v1.2 Week 3-4 follow-up v1.2 Prescription issue v1.0 No set visit v1.0 Outcome v1.0 Serious Adverse Event v1.0 (see also list of sub-categories) Data correction request v1.0 Please log in to download a zip archive of printable CRFs. Participant contact details should be submitted directly online. A printable preview of the contact details form is available here.
	To read PDF documents, you may need to install Acrobat Reader first. Please click here if you require installation instructions.

Switch to mobile site